|
CeloNova BioSciences, Inc
|
|
|
|
The CATANIA™ Coronary Stent System has been developed using Polyzene®-F, an inorganic polymer that bestows exceptional anti-thrombogenicity, biocompatibility, lubricity, and vastly improves the performance of the device. The unique characteristics of this stent make it particularly attractive for use in patients who are unable to go through traditional long-term dual anti-platelet therapy.
|